Trial intelligence / Profile preview

Sodium bicarbonate for vascular function in CKD stage IV

NCT02031770Completed

Sponsor
University of Colorado Denver
Start
Jan 2014
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of sodium bicarbonate in metabolic acidosis, sponsored by University of Colorado Denver. Primary endpoint: Brachial Artery Flow Mediated Dilation at 12 weeks. Started Jan 2014; status: completed.

02

Drugs

sodium bicarbonate
03

Conditions

metabolic acidosis

Beyond the preview

Go deeper on NCT02031770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02031770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call